Leverages the most advanced technology platform available for the creation of synthetically engineered, therapeutic microbes with the potential to make significant advancements in the treatment of disease
- Year invested 2014
- Investment Stage Seed
- Board Members
- Sectors
- Investment Status Current
- Website synlogictx.com/
- Company Status IPO/Public (NASDAQ: SYBX)